Cell surface receptors are targets of ~50% of pharmaceutical and biological drugs. Still many of such receptors have no known therapeutic inhibitors because 1) the receptors are only active in cells 2) isolation and purification of the receptor is not viable and 3) determining activity of a potential therapeutic is complicated by binding that can […]
Read More